Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-02-14
4:07 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Avidity Partners Management LP2,189,719
9.9%
69,719increase
(+3.29%)
View
2023-02-14
06:15 am
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
Bain Capital Life Sciences Fund II L.P.2,124,694
11%
-4,139,726decrease
(-66.08%)
View
2023-02-10
7:41 pm
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
Artal International S.C.A.1,463,829
7.2%
-2,036,171decrease
(-58.18%)
View
2023-01-27
6:01 pm
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
Ally Bridge MedAlpha Master Fund L.P.1,439,379
6.9%
-2,491,141decrease
(-63.38%)
View
2023-01-25
5:00 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
ADAGE CAPITAL PARTNERS GP L.L.C.1,253,828
6.04%
1,253,828increase
(New Position)
View
2022-11-10
11:55 am
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
FMR LLC104,614
0.516%
-5,693,262decrease
(-98.20%)
View
2022-09-20
4:35 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Avidity Partners Management LP2,120,000
9.9%
2,120,000increase
(New Position)
View
2022-09-19
4:07 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Deep Track Capital LP699,281
9.99%
699,281increase
(New Position)
View
2022-09-16
4:31 pm
Sale
13DSyros Pharmaceuticals, Inc.
SYRS
TYME TECHNOLOGIES INC.
TYME
0
0%
-17,460,552decrease
(Position Closed)
View
2022-07-13
5:15 pm
Purchase
13DSyros Pharmaceuticals, Inc.
SYRS
TYME TECHNOLOGIES INC.
TYME
17,460,552
28%
17,460,552increase
(New Position)
View
2022-07-13
5:10 pm
Purchase
13DTYME TECHNOLOGIES INC.
TYME
Syros Pharmaceuticals Inc.
SYRS
17,819,723
9.9%
17,819,723increase
(New Position)
View
2022-07-08
4:57 pm
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
BlackRock Inc.
BLK
1,524,309
2.4%
-2,707,959decrease
(-63.98%)
View
2022-04-11
09:01 am
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
FMR LLC5,797,876
9.298%
-3,534,921decrease
(-37.88%)
View
2022-02-14
06:41 am
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Bain Capital Life Sciences Fund II L.P.6,264,420
11%
479,384increase
(+8.29%)
View
2022-02-14
06:06 am
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
Nikko Asset Management Americas Inc.0
0%
-4,381,992decrease
(Position Closed)
View
2022-02-11
4:17 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Ally Bridge MedAlpha Master Fund L.P.3,930,520
6.3%
897,395increase
(+29.59%)
View
2022-02-11
06:28 am
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
Artal International S.C.A.3,500,000
5.6%
3,500,000increase
(New Position)
View
2022-02-09
10:01 am
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
FMR LLC9,332,797
14.999%
2,420,462increase
(+35.02%)
View
2022-02-04
06:09 am
Sale
13GSyros Pharmaceuticals, Inc.
SYRS
Sumitomo Mitsui Trust Holdings Inc.0
0%
-4,381,992decrease
(Position Closed)
View
2022-02-03
4:41 pm
Purchase
13GSyros Pharmaceuticals, Inc.
SYRS
BlackRock Inc.
BLK
4,232,268
6.8%
906,708increase
(+27.26%)
View
Goto 0, 1, 2, Next